Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Neuroscience

Bob S. Carter, MD, PhD, is the chief of the Department of Neurosurgery at Massachusetts General Hospital. In this Q&A, Dr. Carter elaborates on intraoperative molecular diagnostics. Dr. Carter is also a 2021 Congress of Neurological Surgeons (CNS) honored guest.

Featured In Digestive Health

Richard A. Hodin, MD, discusses his surgical work, the improved outcomes he sees in patients who undergo J-pouch surgery and his experience maintaining longer-term relationships with patients.

Featured In Orthopaedics

Researchers in the Sports Medicine Service have determined that instructing baseball pitchers in the ideal kinematic sequence (the pattern of energy transfer in the body) could protect them from injury to the shoulder and elbow, regardless of whether they throw from the traditional windup or the stretch delivery.

Featured In Urology

Researchers explore long-term outcomes and options for bladder cancer recurrence after combination treatment using transurethral resection and chemoradiation.

Featured In Endocrinology

Cheng-Chia Tang, PhD, and Marc N. Wein, MD, PhD, of the Endocrine Unit, and colleagues demonstrated in a preclinical osteoporosis model that an oral drug, YKL-05–099, boosts bone formation and trabecular bone mass—and unlike current anabolic osteoporosis therapies, inhibits bone resorption.

The Latest Cardiovascular Advances

Harald C. Ott, MD, and Jun Jie Tan, DPhil, of the Center for Regenerative Medicine, and colleagues have devised a straightforward method of generating pre-epicardial cells that should play a key role in creating bioengineered heart tissue to treat patients with heart failure.

Patrick T. Ellinor, MD, PhD, of the Demoulas Center for Cardiac Arrhythmias at Massachusetts General Hospital, Sekar Kathiresan, MD, formerly of the Center for Genomic Medicine, and colleagues have demonstrated that the catalytic domain of ADAMTS7 is a promising therapeutic target for coronary artery disease.

Contributing Physicians

Director of the Echocardiography Lab, Division of Cardiology, Professor of Medicine, Harvard Medical School

Judy Wei-Ming Hung, MD

Director, Cardiac Arrhythmia Service

Patrick Ellinor, MD, PhD

Advances Specialties

Geriatrics and Palliative Care

Massachusetts General Hospital researchers demonstrated that intensive therapy for aggressive non-Hodgkin's lymphoma has survival benefits across all age brackets of older adults, and they identified factors associated with greater risk of toxicities and unplanned hospitalization.

OB/GYN

Massachusetts General Hospital researchers present evidence that fetal sex plays a key role in modifying maternal humoral responses and placental innate and adaptive immune responses. They found significantly reduced transfer of SARS-CoV-2–specific antibodies to male fetuses.

Pulmonary and Critical Care

Lorenzo Berra, MD, and Bijan Safaee Fakhr, MD, of the Department of Anesthesia, Critical Care and Pain Medicine, and colleagues found that high-dose inhaled nitric oxide produced a beneficial effect on the respiratory system of non-intubated hospitalized COVID-19 patients without adverse events.

Education & Training Opportunities

December 8, 2021 - July 13, 2022

The Massachusetts General Hospital Corrigan Minehan Heart Center prepares future health care professionals and trains providers in innovative therapies and care. As part of these efforts, the center hosts regular Grand Rounds presentations from thought leaders and researchers on important cardiology topics. Cardiology Grand Rounds is open to all healthcare professionals.

November 5-6, 2021

The Mass General Short-term Heart/Lung Support Symposium is designed to provide the opportunity to learn, ask questions, participate in simulation exercises and review the rare but potentially fatal problems that can occur with all forms of mechanical assist in a low stress environment for all team members.

Clinical Trials

In Neuroscience

The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.

In Neuroscience

We are looking for adults 55-80 years old with Alzheimer's Disease to receive infusions of an experimental drug, JNJ-63733657, or a placebo (inactive) infusion. This study will help us determine the safety and efficacy of JNJ-63733657.